Outlook Therapeutics, Inc. (NASDAQ:OTLK) filed a Form 8-K with the Securities and Exchange Commission on February 18, 2026, disclosing a material event.
Outlook Therapeutics, Inc.'s stock currently trades at $0.41 with a market capitalization of $89.3M. The Healthcare company's stock moved following the disclosure.